- Display 15 Products per page
Published: October 1, 2004 | Price: $395.00 – $790.00
Based on findings from Kalorama Information’s research study Facial Cosmetic Surgery and Rejuvenation Markets: Business, Technologies, and Competitive Intelligence (July 2004), this summary covers the top five surgeries and an “other” category. The top five procedures are: Breast augmentation/reduction Liposuction Rytidectomy (face lifts) Blepharoplasty (eyelid lift) Rhinoplasty (nose job) The analysis includes data on procedures and revenues for surgery but not market data for conventional surgical instruments and equipment. The “other” category includes such procedures as tummy tucks , buttocks...Published: September 1, 2004 | Price: $3,500.00 – $7,000.00
Neural and muscular stimulation by electronic and magnetic means have evolved into a burgeoning product development and commercial fields. For decades, transcutaneous electronic nerve stimulation (TENS) has been a mainstay in the pain relief arsenal. Through the years, as biocompatibility problems were being solved, electrode and sensor implants developed into a multitude of technologies with healthcare applications. The growing approval of these applications by government regulators and the growing acceptance by insurance carriers have driven the market. These techniques have...Published: August 1, 2004 | Price: $995.00 – $1,910.00
Blood banking has been the most dynamic testing segment to adopt molecular diagnostics approaches since their introduction. Screening for HIV, HCV and HBV in donated blood, plasma and organs has largely been done by immunoassay procedures. In conjunction with background screening, this has become a very effective approach toward guaranteeing the safety of the blood/organ supply. However, there is a lag time between infection with these viruses and the production of antibodies against them. In some cases, such as HBV,...Published: July 1, 2004 | Price: $3,500.00 – $7,000.00
New technologies and alternatives to traditional cosmetic surgery have opened up a huge new market for anti-aging products. Cosmetic facial rejuvenation is no longer the purview of plastic surgeons, but represents a booming cash business for a large number of dermatologist and other practitioners. Botox, dermal fillers, resurfacing modalities, lasers, and other alternatives are creating a dynamic and growing marketplace and finding millions of eager patients. This 400-page report examines the competing technologies, procedures, and options available to physicians, non-physician...Published: July 1, 2004 | Price: $895.00 – $1,790.00
Alternative routes of administration for insulin has been one of the leading drivers of drug delivery industry. Although transdermal and transmucosal systems have shown promise and true oral delivery remains a goal, pulmonary delivery has emerged as the leading area of development. Several major players in the pharmaceutical industry have given their backing to inhaled insulin projects, and product launches are imminent. However, the exact make-up of the market, patient acceptance, and regulatory progress are still not completely clear. This...Published: March 1, 2004 | Price: $3,500.00 – $7,000.00
The dialysis industry enjoys a unique space in healthcare sector. The industry has its feet spread across the two most lucrative segments of the sector viz. medical devices industry (dialysis products and supplies segment) and healthcare services industry (dialysis services segment). Needless to say, the dialysis industry remains a robust, nearly $50 billion global industry that has managed to fuel its growth engine with a modest, but respectable 6% to 7% rise growth rate in the past 5 years. The...Published: September 1, 2003 | Price: $1,875.00 – $3,750.00
Wound care has come into its own in the last five years and is now recognized as a specialty. The field has become so diverse and dynamic that studying “the wound care market” as a whole is no longer instructive. As technologies begin to be commercialized and products hit the market, segmentation by application is the key to understanding market potential. This Kalorama specialty report will focus on the products that are currently on the market for surgical and trauma...Published: September 1, 2003 | Price: $6,000.00 – $12,000.00
Wound care has come into its own in the last five years and is now recognized as a specialty. The field has become so diverse and dynamic that studying “the wound care market” as a whole is no longer instructive. As technologies begin to be commercialized and products hit the market, segmentation by application is the key to understanding market potential. Kalorama has undertaken a major study to examine each of the three main market segments, in turn: Volume I:...Published: August 1, 2003 | Price: $1,875.00 – $3,750.00
Wound care has come into its own in the last five years and is now recognized as a specialty. The field has become so diverse and dynamic that studying “the wound care market” as a whole is no longer instructive. As technologies begin to be commercialized and products hit the market, segmentation by application is the key to understanding market potential. This Kalorama specialty report will focus on the products that are currently on the market for wound care for...Published: June 1, 2003 | Price: $1,875.00 – $3,750.00
Wound care has come into its own in the last five years and is now recognized as a specialty. The field has become so diverse and dynamic that studying “the wound care market” as a whole is no longer instructive. As technologies begin to be commercialized and products hit the market, segmentation by application is the key to understanding market potential. This Kalorama specialty report will focus on the products that are currently on the market for wound care for...Published: June 1, 2003 | Price: $995.00 – $2,992.00
According to the Pharmaceutical Research and Manufacturers of America (PhRMA) more than 1,000 drugs are in various stages of development. Similarly, breakthroughs in the medical device arena such as coronary stents, implantable defibrillators, and minimally invasive bypass surgery and advances in DNA-based tests and other advanced diagnostics are detecting cancer and other diseases earlier when they are more treatable are moving from dream to reality. It is obvious that even if all of these drugs and devices make it to...Published: April 1, 2003 | Price: $1,875.00 – $3,750.00
Each year in the United States, more than 500,000 people with coronary artery disease are treated with percutaneous transluminal coronary angioplasty (PTCA). Unfortunately, restenosis occurs within three to six months in 40% to 50% of PTCA patients due to either thrombosis or abnormal tissue growth. As a result, restenosis constitutes the major limitation to the effectiveness of PTCA. To improve on this condition, medical science created stents in an attempt to keep coronary arteries open. However, one of the early...Published: April 1, 2003 | Price: $371.00 – $742.00
The market for diabetes care products covers the spectrum of clinical medicine, including diagnostics, biologics, and drugs. Several areas have strong growth potential and others, such as drugs to treat complications, represent large underserved markets for drugs primarily marketed to other populations. Segmentation of patient populations in novel ways, such as diabetic candidates for cardiovascular drugs, presents an excellent opportunity to expand markets and influence prescription practices in some markets. Scope and Methodology In addition to epidemiology of diabetes Type...Published: April 1, 2003 | Price: $371.00 – $742.00
The market for diabetes care products covers the spectrum of clinical medicine, including diagnostics, biologics, and drugs. Several areas have strong growth potential and others, such as drugs to treat complications, represent large underserved markets for drugs primarily marketed to other populations. Segmentation of patient populations in novel ways, such as diabetic candidates for cardiovascular drugs, presents an excellent opportunity to expand markets and influence prescription practices in some markets. Scope and Methodology In addition to epidemiology of diabetes Type...Published: March 1, 2003 | Price: $371.00 – $742.00
Diabetes monitoring and therapeutics to manage the disease and its complications continues to be an attractive market for many manufacturers. However, the factors that affect the potential of diabetes markets—including population demographics and the attitude of healthcare policy makers and clinicians—can seem like shifting sands from one country to the next. That’s why Kalorama is now offering affordable country-specific profiles on the diabetes markets that provide you with the facts you need to implement your strategy in each of the...